Skip to content
OpenCapital
Get started

Palisade Bio, Inc. PALI Q1 2026 earnings

Reported May 12, 2026 · After market close

EPS-$0.05Miss by $0.01
EPS estimate-$0.04

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.05

Versus estimates

Revenue

Q4 2024$4.0K

Diluted EPS

Q1 2026-$0.05Miss by $0.01
Q4 2025-$0.04Miss by $0.02Q3 2025-$0.38Miss by $0.06Q2 2025-$0.58Miss by $0.10Q1 2025-$0.47Beat by $0.37Q4 2024-$0.69Beat by $1.30

Ask the moment Palisade Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Palisade Bio, Inc. report Q1 2026 earnings?
Palisade Bio, Inc. (PALI) reported Q1 2026 earnings on May 12, 2026 after market close.
What were Palisade Bio, Inc.'s Q1 2026 revenue and EPS?
Palisade Bio, Inc. reported eps of $-0.05 for Q1 2026.
Did Palisade Bio, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.04 by $0.01.
How did Palisade Bio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 89.4% from $-0.47.
Where can I find Palisade Bio, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001357459-26-000011) and the 10-Q periodic report (0001357459-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.